Skip to search.
 All Ordinaries Down 1.47%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
0.39 Down 0.02(3.84%) 01:27 - Nasdaq Real-Time Price
Prev Close:0.41
Open:0.41
Bid:0.39 x 100
Ask:0.39 x 300
1y Target Est:1.00
Beta:0.875801
Next Earnings Date:N/A
Day's Range:0.39 - 0.41
52wk Range:0.15 - 2.65
Volume:242,840
Avg Vol (3m):1,349,860
Market Cap:53.71M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTADown 3.84%53.71M
INFIDown 6.74%259.80M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.07
Quarterly EPS Est (Mar-16) :-0.03
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback